FDA panel reviewing Pfizer vaccine for children
The Food and Drug Administration is hosting a public meeting Tuesday that is a key step in deciding whether to open COVID-19 vaccinations to kids aged 5 to 11.
The Food and Drug Administration is hosting a public meeting Tuesday that is a key step in deciding whether to open COVID-19 vaccinations to kids aged 5 to 11.